Van Well Daan 4

What Happened
Daan Van Well, Chief Legal Officer of SOPHiA GENETICS (SOPH), sold a total of 4,849 shares in two open‑market transactions to satisfy tax withholding on recently vested restricted stock units. On 2026‑04‑08 he sold 2,861 shares at a weighted average price of $4.85 for proceeds reported as $13,862. On 2026‑04‑09 he sold 1,988 shares at a weighted average price of $4.74 for proceeds reported as $9,424. These were sales (not purchases).

Key Details

• Transaction dates: 2026‑04‑08 (2,861 shs @ $4.85, reported $13,862) and 2026‑04‑09 (1,988 shs @ $4.74, reported $9,424). Total sold: 4,849 shares for ~$23,286.
• Price ranges: 4/8 sale prices ranged $4.78–$4.94 (weighted avg $4.85); 4/9 sale prices ranged $4.61–$4.86 (weighted avg $4.74). Reporting person will provide breakdown by price on request.
• Purpose and plan: Sales were made to satisfy tax withholding on RSU vesting (April 2 and 3, 2026) and were effected under a pre‑established Rule 10b5‑1 trading plan — non‑discretionary routine transactions.
• Filing timeliness: Form 4 filed 2026‑04‑10 for transactions on 4/8 and 4/9 — appears to be timely (not marked late).
• Post‑transaction holdings: Not specified in the provided excerpt of the filing.

Context
These sales were tax‑withholding transactions tied to RSU vesting and executed under a 10b5‑1 plan, which is common and generally considered routine rather than a directional signal about the company. Retail investors may view routine tax‑related sales differently than discretionary insider selling; purchases by insiders tend to be more informative about confidence in the stock.